Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma - Poll - MDSpire

Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma

  • By

  • Xingqiang Ran

  • Chengcheng Zhang

  • Li Zheng

  • Tao Luo

  • Binwen Xu

  • Yue Zhang

  • Liwen Zhang

  • Bo Yang

  • Maoyong Fu

  • December 11, 2025

  • 0 min

Share

Original Source(s)

Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma

  • by Xingqiang Ran, Chengcheng Zhang, Li Zheng, Tao Luo, Binwen Xu, Yue Zhang, Liwen Zhang, Bo Yang, Maoyong Fu

  • December 11, 2025

Related Content

Dose-dependent tuning of HSP70–Beclin-1 by kaempferol governs autophagy and chemosensitivity

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and